These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 30916409)

  • 1. Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis.
    Murphy MSQ; Tinmouth A; Goldman M; Chassé M; Colas JA; Saidenberg E; Shehata N; Fergusson D; Forster AJ; Wilson K
    Transfusion; 2019 Jun; 59(6):1988-1996. PubMed ID: 30916409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical indications for intravenous immunoglobulin utilization in a tertiary medical center: a 9-year retrospective study.
    Shemer A; Kivity S; Shoenfeld Y
    Transfusion; 2018 Feb; 58(2):430-438. PubMed ID: 29193136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulin in paediatric neurology: safety, adherence to guidelines, and long-term outcome.
    Nosadini M; Mohammad SS; Suppiej A; Sartori S; Dale RC;
    Dev Med Child Neurol; 2016 Nov; 58(11):1180-1192. PubMed ID: 27242065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumococcal antibody levels in children with PID receiving immunoglobulin.
    Tuerlinckx D; Florkin B; Ferster A; De Schutter I; Chantrain C; Haerynck F; Philippet P; Strengers P; Laub R
    Pediatrics; 2014 Jan; 133(1):e154-62. PubMed ID: 24366995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Audit of provincial IVIG Request Forms and efficacy documentation in four Ontario tertiary care centres.
    Shih AW; Jamula E; Diep C; Lin Y; Armali C; Heddle NM; Traore A; Doherty J; Shah N; Hillis CM
    Transfus Med; 2017 Apr; 27(2):122-131. PubMed ID: 28144996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating dose ratio of subcutaneous to intravenous immunoglobulin therapy among patients with primary immunodeficiency disease switching to 20% subcutaneous immunoglobulin therapy.
    Krishnarajah G; Lehmann JK; Ellman B; Bhak RH; DerSarkissian M; Leader D; Bullinger AL; Sheng Duh M
    Am J Manag Care; 2016 Oct; 22(15 Suppl):s475-s481. PubMed ID: 27849353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in intravenous immunoglobulin prescribing patterns during a period of severe product shortages, 1995-2000.
    Pendergrast JM; Sher GD; Callum JL
    Vox Sang; 2005 Oct; 89(3):150-60. PubMed ID: 16146507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-minimization analysis of IgPro20, a subcutaneous immunoglobulin, in Japanese patients with primary immunodeficiency.
    Igarashi A; Kanegane H; Kobayashi M; Miyawaki T; Tsutani K
    Clin Ther; 2014 Nov; 36(11):1616-24. PubMed ID: 25236916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin treatment of immunodeficiency disorders.
    Schwartz SA
    Pediatr Clin North Am; 2000 Dec; 47(6):1355-69. PubMed ID: 11131000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous immune globulin use in Canada.
    Hanna K; Poulin-Costello M; Preston M; Maresky N
    Can J Clin Pharmacol; 2003; 10(1):11-6. PubMed ID: 12687032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous immunoglobulin in neonates at a tertiary academic hospital: a retrospective 11-year study.
    Lieberman L; Spradbrow J; Keir A; Dunn M; Lin Y; Callum J
    Transfusion; 2016 Nov; 56(11):2704-2711. PubMed ID: 27459953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hand-foot-mouth disease and use of steroids, intravenous immunoglobulin, and traditional Chinese herbs in a tertiary hospital in Shantou, China.
    Zhang D; Chen J; Ba-Thein W
    BMC Complement Altern Med; 2018 Jun; 18(1):190. PubMed ID: 29925360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intravenous immunoglobulin G (IVIG).
    Looney RJ; Huggins J
    Best Pract Res Clin Haematol; 2006; 19(1):3-25. PubMed ID: 16377538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of a nanofiltered liquid intravenous immunoglobulin product in patients with primary immunodeficiency and idiopathic thrombocytopenic purpura.
    van der Meer JW; van Beem RT; Robak T; Deptala A; Strengers PF
    Vox Sang; 2011 Aug; 101(2):138-46. PubMed ID: 21749402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacovigilance study of a regional intravenous immunoglobulin (II): evaluation and comparison of an improved pharmaceutical form.
    Mahieu AC; Sisti AM; Joekes S; Manfredi MJ
    Allergol Immunopathol (Madr); 2006; 34(6):242-7. PubMed ID: 17173840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease burden for patients with primary immunodeficiency diseases identified at reference hospitals in Guanajuato, Mexico.
    Guaní-Guerra E; Jiménez-Romero AI; García-Ramírez UN; Velázquez-Ávalos JM; Martínez-Guzmán E; Sandoval-Ramírez E; Camacho-Meza I
    PLoS One; 2017; 12(4):e0175867. PubMed ID: 28448570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous Immunoglobin Utilization Study in a Teaching Hospital.
    Rezaie N; Shajareh E; Motamed MR; Ghanbari B; Pakdaman N; Farasatinasab M
    Arch Iran Med; 2019 May; 22(5):232-235. PubMed ID: 31256594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of intravenous immunoglobulin in an Asian paediatric population over a 10-year period.
    Wu J; Lee AJ; Goh AE; Chia M; Ho C; Bugarin JL; Shek LP; Chan YH; Lee BW
    J Paediatr Child Health; 2013 Aug; 49(8):629-34. PubMed ID: 23750995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Immunoglobulin (IVIg) Utilization in Immune Thrombocytopenia (ITP): A Multi-Center, Retrospective Review.
    Hsia CC; Liu Y; Eckert K; Monga N; Elia-Pacitti J; Heddle NM
    Drugs Real World Outcomes; 2015 Mar; 2(1):35-42. PubMed ID: 27747610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Efficacy of Intravenous Immunoglobulin in Guillain-Barré Syndrome: The Experience of a Tertiary Medical Center.
    Shalem D; Shemer A; Shovman O; Shoenfeld Y; Kivity S
    Isr Med Assoc J; 2018 Dec; 20(12):754-760. PubMed ID: 30550005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.